2015 | Pathological Evaluation of Radiation-Induced Vascular Lesions of the Brain: Distinct from De Novo Cavernous Hemangioma
| YONSEI MEDICAL JOURNAL |
2022 | Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study | JOURNAL OF NEUROSURGERY |
2011 | Peripheral compressing artifacts in brain tissue from stereotactic biopsy with sidecutting biopsy needle: a pitfall for adequate glioma grading.
| CLINICAL NEUROPATHOLOGY |
2007 | Pleomorphic adenocarcinoma of the lacrimal gland with multiple intracranial and spinal metastases
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
2020 | Predicting survival using the 2016 World Health Organization classification for anaplastic glioma | CLINICAL NEUROPATHOLOGY |
2018 | Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas | AMERICAN JOURNAL OF NEURORADIOLOGY |
2014 | Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging | JOURNAL OF NEUROSURGERY |
2018 | Prediction of Overall Survival Based on Isocitrate Dehydrogenase 1 Mutation and 18F-FDG Uptake on PET/CT in Patients With Cerebral Gliomas | CLINICAL NUCLEAR MEDICINE |
2018 | Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach | EUROPEAN RADIOLOGY |
2017 | Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient | EUROPEAN RADIOLOGY |
2015 | Primary diffuse leptomeningeal gliosarcomatosis
| Brain Tumor Research and Treatment |
2018 | Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
2023 | Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study
| KOREAN JOURNAL OF RADIOLOGY |
2021 | Quality assessment of meningioma radiomics studies: Bridging the gap between exploratory research and clinical applications | EUROPEAN JOURNAL OF RADIOLOGY |
2022 | Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation
| KOREAN JOURNAL OF RADIOLOGY |
2001 | Radiologically Confirmed de novo Glioblastoma Multiforme and Hippocampal Sclerosis Associated with the First Onset of Nonconvulsive Simple Partial Status Epilepticus | ACTA NEUROCHIRURGICA |
2018 | Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction | RADIOLOGY |
2019 | Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging | European Radiology |
2019 | Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors
| Korean Journal of Radiology |
2020 | Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas | EUROPEAN RADIOLOGY |
2021 | Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant
| JOURNAL OF NEURO-ONCOLOGY |
2011 | Radiosurgery for radiosurgery-induced cavernous malformation | WORLD NEUROSURGERY |
2019 | Re-evaluation of the diagnostic performance of 11C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomas | European Journal of Nuclear Medicine and Molecular Imaging |
2011 | Recurred cerebellopontine angle haemangiopericytoma 5 years after stereotactic radiosurgery | CLINICAL NEUROLOGY AND NEUROSURGERY |
2018 | Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
| SCIENTIFIC REPORTS |
2016 | Report of a rare case of atypical lymphoplasmacyte-rich meningioma in the tentorium mimicking idiopathic hypertrophic pachymeningitis | BRAIN TUMOR PATHOLOGY |
2024 | Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification | EUROPEAN RADIOLOGY |
2023 | Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities
| JOURNAL OF NEURO-ONCOLOGY |
2003 | Secretory Meningioma with Elevated Serum Carcinoembryonic Antigen
| Journal of Korean Neurosurgical Society (대한신경외과학회지) |
2022 | Sex as a prognostic factor in adult-type diffuse gliomas: an intergrated clinical and molecular analysis according to the 2021 WHO classification | JOURNAL OF NEURO-ONCOLOGY |
2003 | Simple bone cyst occurring in calvarium | ACTA NEUROCHIRURGICA |
2019 | Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classification | JOURNAL OF NEUROSURGERY |
2013 | Solitary Primary Leptomeningeal Glioma: Case Report
| Brain Tumor Research and Treatment |
2016 | Success of tumorsphere isolation from WHO grade IV gliomas does not correlate with the weight of fresh tumor specimens: an immunohistochemical characterization of tumorsphere differentiation
| CANCER CELL INTERNATIONAL |
2020 | Survival benefit of lobectomy over gross-total resection without lobectomy in cases of primary glioblastoma in non-eloquent area: a retrospective study | JOURNAL OF NEUROSURGERY |
2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
2005 | Sylvian meningioma without dural attachment in an adult | JOURNAL OF NEURO-ONCOLOGY |
2019 | Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases | JOURNAL OF NEURO-ONCOLOGY |
2016 | Terahertz reflectometry imaging for low and high grade gliomas
| SCIENTIFIC REPORTS |
2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors | JOURNAL OF MAGNETIC RESONANCE IMAGING |
2015 | The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival | AMERICAN JOURNAL OF NEURORADIOLOGY |
2019 | The added prognostic value of radiological phenotype combined with clinical features and molecular subtype in anaplastic gliomas | JOURNAL OF NEURO-ONCOLOGY |
2017 | The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter | AMERICAN JOURNAL OF NEURORADIOLOGY |
2021 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
| Brain Tumor Research and Treatment |
2021 | The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | ANNALS OF HEMATOLOGY |
2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | BRITISH JOURNAL OF HAEMATOLOGY |
2018 | The roles of (11)C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2022 | Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas
| PLOS ONE |
2019 | Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
| Scientific Reports |
2019 | Treatment outcomes of radiotherapy for primary spinal cord glioma | STRAHLENTHERAPIE UND ONKOLOGIE |
2020 | Ttreatment results for recurrent glioblastoma and alteration of PD-L1 expression after recurrence | WORLD NEUROSURGERY |
2022 | Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |